Agency Information Collection Activities; Proposed Collection; Unique Device Identification System; Extension of Comment Period
Notification; Extension Of Comment Period.
The Food and Drug Administration (FDA) is extending the comment period pertaining to information collection issues under the Paperwork Reduction Act of 1995 (the PRA) associated with the proposed rule, Unique Device Identification System, that appeared in the Federal Register of July 10, 2012 (77 FR 40736). The Agency is taking this action in response to requests for an extension to allow interested persons additional time to submit comments.
5 actions from July 10th, 2012 to July 2013
July 10th, 2012
November 7th, 2012
- NPRM Comment Period End
November 19th, 2012
- Second NPRM
December 19th, 2013
- Second NPRM Comment Period End
- Final Action
Table of Contents Back to Top
DATES: Back to Top
Submit either electronic or written comments on the proposed collection of information by October 25, 2012.
ADDRESSES: Back to Top
Submit electronic comments on the collection of information to the Office of Regulatory Affairs, Office of Management and Budget (OMB) at FAX: 202-395-7285, or email comments to OIRA_submissions@omb.eop.gov. Please mark your comment to the FDA desk officer and reference this rule.
FOR FURTHER INFORMATION CONTACT: Back to Top
Jay Crowley, Center for Devices and Radiological Health, Food and Drug Administration, 10903 New Hampshire Ave., Silver Spring, MD 20993, 301-796-5995, email: firstname.lastname@example.org.
SUPPLEMENTARY INFORMATION: Back to Top
I. Background Back to Top
In the Federal Register of July 10, 2012 (77 FR 40736), FDA published a notice of proposed rulemaking with a 60-day comment period concerning the proposed information collection. Comments on the proposed rulemaking will inform FDA's rulemaking to establish regulations for Unique Device Identification System.
The Agency has received requests for a 45-day extension of the comment period for the information collection. Each request conveyed concern that the current 60-day comment period does not allow sufficient time to develop a meaningful or thoughtful response to the information collection.
FDA has considered the requests and is extending the comment period for the information collection for 45 days, until October 25, 2012. The Agency believes that a 45-day extension allows adequate time for interested persons to submit comments without significantly delaying rulemaking on these important issues.
Dated: September 12, 2012.
Assistant Commissioner for Policy.
[FR Doc. 2012-22821 Filed 9-14-12; 8:45 am]
BILLING CODE 4160-01-P